FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Georgene Schroeder

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Bone Marrow

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Ruben A Mesa; Chin-Yang Li; Rhett P Ketterling; Georgene Schroeder; Ryan A Knudson; Ayalew Tefferi
Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.
Ruben A Mesa; Michelle A Elliott; Georgene Schroeder; Ayalew Tefferi
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
Ruben A Mesa; Ayalew Tefferi; Leigh A Gray; Terra L Reeder; Georgene Schroeder; Scott H Kaufmann
In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Georgene Schroeder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Ruben A Mesa; Chin-Yang Li; Rhett P Ketterling; Georgene Schroeder; Ryan A Knudson; Ayalew Tefferi
Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases.
Blood 2005;105(3):973-7.
2004: Ruben A Mesa; Michelle A Elliott; Georgene Schroeder; Ayalew Tefferi
Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):883-9.
2003: Ruben A Mesa; Ayalew Tefferi; Leigh A Gray; Terra L Reeder; Georgene Schroeder; Scott H Kaufmann
In vitro antiproliferative activity of the farnesyltransferase inhibitor R115777 in hematopoietic progenitors from patients with myelofibrosis with myeloid metaplasia.
Leukemia 2003;17(5):849-55.
2003: Ruben A Mesa; David P Steensma; Animesh Pardanani; Chin-Yang Li; Michelle Elliott; Scott H Kaufmann; Gregory Wiseman; Leigh A Gray; Georgene Schroeder; Terra L Reeder; Jerome B Zeldis; Ayalew Tefferi
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia.
Blood 2003;101(7):2534-41.
2003: Animesh Pardanani; Thomas E Witzig; Georgene Schroeder; Edwin A McElroy; Rafael Fonseca; Angela Dispenzieri; Martha Q Lacy; John A Lust; Robert A Kyle; Philip R Greipp; Morie A Gertz; S Vincent Rajkumar
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Blood 2003;101(3):827-30.
2002: Mark R Litzow; Panagiotis D Repoussis; Georgene Schroeder; David Schembri-Wismayer; Kenneth P Batts; Peter M Anderson; Carola A S Arndt; Michael G Chen; Dennis A Gastineau; Morie A Gertz; David J Inwards; Martha Q Lacy; Ayalew Tefferi; Pierre Noël; Lawrence Solberg; Louis Letendre; H Clark Hoagland
Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
Leukemia & lymphoma 2002;43(11):2099-107.
2002: S Vincent Rajkumar; Ruben A Mesa; Rafael Fonseca; Georgene Schroeder; Matthew F Plevak; Angela Dispenzieri; Martha Q Lacy; John A Lust; Thomas E Witzig; Morie A Gertz; Robert A Kyle; stephen russell; Philip R Greipp
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
2002: Ruben A Mesa; Curtis A Hanson; Chin-Yang Li; Soo-Young Yoon; S Vincent Rajkumar; Georgene Schroeder; Ayalew Tefferi
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia.
Blood 2002;99(11):4131-7.
2002: Ayalew Tefferi; Ruben A Mesa; Leigh A Gray; David P Steensma; John K Camoriano; Michelle A Elliott; Animesh Pardanani; Stephen M Ansell; Timothy G Call; Gerardo Colon-Otero; Georgene Schroeder; Curtis A Hanson; Gordon W Dewald; Scott H Kaufmann
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Blood 2002;99(10):3854-6.
2001: Ruben A Mesa; Ayalew Tefferi; Michelle A Elliott; H Clark Hoagland; Timothy G Call; Georgene Schroeder; Soo-Young Yoon; Chin-Yang Li; Leigh A Gray; S Margolin; C Christopher Hook
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.
British journal of haematology 2001;114(1):111-3.
2001: Ayalew Tefferi; Ruben A Mesa; Georgene Schroeder; Curtis A Hanson; Chin-Yang Li; Gordon W Dewald
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
British journal of haematology 2001;113(3):763-71.
2001: Ruben A Mesa; Chin-Yang Li; Georgene Schroeder; Ayalew Tefferi
Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
Blood 2001;97(11):3665-7.
2001: Ayalew Tefferi; Michelle A Elliott; David P Steensma; C Christopher Hook; A Dispenzieria; Curtis A Hanson; Georgene Schroeder; Louis Letendre
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome.
Leukemia research 2001;25(2):183-5.
2000: Ruben A Mesa; Curtis A Hanson; S Vincent Rajkumar; Georgene Schroeder; Ayalew Tefferi
Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.
Blood 2000;96(10):3374-80.
2000: Patrick A Burch; C Ghosh; Georgene Schroeder; Cristine Allmer; C L Woodhouse; Richard M Goldberg; Ferdinand K Addo; Albert M Bernath; Loren K Tschetter; Harold E Windschitl; Charles D Cobau
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2000;23(5):534-7.
2000: Patrick A Burch; M Block; Georgene Schroeder; John W Kugler; Daniel J Sargent; Theodore A Braich; James A Mailliard; John C Michalak; Alan K Hatfield; K Wright; Steven A Kuross
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3486-92.
2000: Ayalew Tefferi; Ruben A Mesa; David M Nagorney; Georgene Schroeder; MN Silverstein
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.
Blood 2000;95(7):2226-33.
1999: Ayalew Tefferi; Ralph Levitt; Chin-Yang Li; Georgene Schroeder; Loren K Tschetter; John C Michalak; James E Krook; Thomas E Witzig
Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
American journal of clinical oncology 1999;22(5):509-16.
1999: Patrick A Burch; M D Keppen; Georgene Schroeder; Joseph Rubin; James E Krook; Robert J Dalton; JB Gerstner; M T Jancewicz; Larry P Ebbert
North Central Cancer Treatment Group Phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survival as the primary endpoint of efficacy.
American journal of clinical oncology 1999;22(5):505-8.
1999: Louis Letendre; P Noel; W L White; Ayalew Tefferi; Mark R Litzow; Chin-Yang Li; Georgene Schroeder
Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara C.
Leukemia research 1999;23(9):811-5.
1999: James A Martenson; Thomas G Shanahan; Michael J O'Connell; Charles D Cobau; Georgene Schroeder; Patrick A Burch; Ralph Levitt; Kendrith M Rowland
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
Cancer 1999;86(4):710-4.
1998: Michael J O'Connell; David M Nagorney; Albert M Bernath; Georgene Schroeder; Robert J Fitzgibbons; James A Mailliard; Patrick A Burch; J S Bolton; Gerardo Colon-Otero; James E Krook
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2528-33.
1998: Thomas E Witzig; John K Camoriano; Georgene Schroeder; Paul J Kurtin; Thomas M Habermann
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;28(3-4):307-14.
1997: Henry C Pitot; Donald B Wender; Michael J O'Connell; Georgene Schroeder; Richard M Goldberg; Joseph Rubin; James A Mailliard; James A Knost; C Ghosh; RJ Kirschling; Ralph Levitt; Harold E Windschitl
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2910-9.
1997: James A Martenson; R Swaminathan; Patrick A Burch; R G Santala; Georgene Schroeder; Henry C Pitot; K Wright; John W Kugler; Philip J Stella; G R Garton
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.
International journal of radiation oncology, biology, physics 1997;37(3):615-8.
1996: Joseph Rubin; J G Gallagher; Georgene Schroeder; A J Schutt; Robert J Dalton; John W Kugler; Roscoe F Morton; James A Mailliard; Patrick A Burch
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma.
Cancer 1996;78(9):1888-91.
1995: J P Garton; Morie A Gertz; Thomas E Witzig; Philip R Greipp; J A Lust; Georgene Schroeder; Robert A Kyle
Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Archives of internal medicine 1995;155(19):2069-74.
1995: Thomas E Witzig; Thomas M Habermann; Paul J Kurtin; Georgene Schroeder; M J Stenson; Philip R Greipp
S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.
Cancer 1995;76(6):1059-64.
1995: Thomas E Witzig; Louis Letendre; JB Gerstner; Georgene Schroeder; James A Mailliard; G Colon-Otero; RF Marschke; Harold E Windschitl
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):2012-5.
1995: Louis Letendre; Ralph Levitt; R V Pierre; Georgene Schroeder; J A Krook; J E Mailliard; Roscoe F Morton; Loren K Tschetter
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid.
American journal of hematology 1995;48(4):233-6.